NASDAQ · Financial Statements
Centessa Pharmaceuticals plc (CNTA) Financial Statements
$40.50
NASDAQ: CNTA
Market Cap $6.27B
Overview Financials Dividend Centessa Pharmaceuticals plc most recently reported annual revenue of $15.0M, net profit of $-198.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $7.0M $0 $15.0M Operating Profit $-375.0M $-212.0M $-171.0M $-201.0M $-208.0M Net Profit $-382.0M $-216.0M $-151.0M $-236.0M $-198.0M EPS $-4.24 $-2.31 $-1.57 $-2.06 $-1.46 Op Margin — — -2499.4% — -1384.6%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $630.0M $444.0M $360.0M $577.0M $687.0M Total Liabilities $138.0M $108.0M $124.0M $175.0M $161.0M Cash $595.0M $394.0M $128.0M $383.0M $61.0M Borrowings $76.0M $70.0M $85.0M $117.0M $8.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-136.0M $-201.0M $-160.0M $-142.0M $-194.0M Investing Cash Flow $63.0M $-2.0M $-127.0M $31.0M $-419.0M Financing Cash Flow $0 $0 $0 $6.0M $-5.0M Net Cash Flow $590.0M $-201.0M $-266.0M $255.0M $-321.0M Free Cash Flow $-136.0M $-202.0M $-161.0M $-142.0M $-194.0M
Valuation & Return Ratios
Metric Value PEG Ratio 3.15 EV / EBITDA -23.84 FCF Yield -3.34% Quick Ratio 9.53 Interest Coverage -22.70 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock